Baird Medical Investment Holdings Limited (NASDAQ:BDMD)’s traded shares stood at 0.74 million during the latest session, with the company’s beta value hitting -0.69. At the last check today, the stock’s price was $8.21, to imply an increase of 51.48% or $2.79 in intraday trading. The BDMD share’s 52-week high remains $13.52, putting it -64.68% down since that peak but still an impressive 87.21% since price per share fell to its 52-week low of $1.05. The company has a valuation of $291.05M, with an average of 1.17 million shares in intraday trading volume over the past 10 days and average of 1.68 million shares over the past 3 months.

Baird Medical Investment Holdings Limited (NASDAQ:BDMD) trade information

After registering a 51.48% upside in the latest session, Baird Medical Investment Holdings Limited (BDMD) has traded red over the past five days. The 5-day price performance for the stock is -7.34%, and 416.35% over 30 days. With these gigs, the year-to-date price performance is 8.03%. Short interest in Baird Medical Investment Holdings Limited (NASDAQ:BDMD) saw shorts transact 80124.0 shares and set a 0.02 days time to cover.

BDMD Dividends

Baird Medical Investment Holdings Limited has its next earnings report out in February. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.